John B. Moriarty, Jr.
2018
In 2018, John B. Moriarty, Jr. earned a total compensation of $4.3M as Executive Vice President, General Counsel and Secretary at Portola Pharmaceuticals.
Compensation breakdown
| Bonus | $200,000 |
|---|---|
| Non-Equity Incentive Plan | $127,300 |
| Option Awards | $2,406,788 |
| Salary | $403,525 |
| Stock Awards | $816,500 |
| Other | $366,157 |
| Total | $4,320,270 |
Moriarty received $2.4M in option awards, accounting for 56% of the total pay in 2018.
Moriarty also received $200K in bonus, $127.3K in non-equity incentive plan, $403.5K in salary, $816.5K in stock awards and $366.2K in other compensation.
Rankings
In 2018, John B. Moriarty, Jr.'s compensation ranked 2,514th out of 14,244 executives tracked by ExecPay. In other words, Moriarty earned more than 82.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,514 out of 14,244 | 82nd |
Division Manufacturing | 926 out of 5,765 | 84th |
Major group Chemicals And Allied Products | 316 out of 2,128 | 85th |
Industry group Drugs | 256 out of 1,817 | 86th |
Industry Pharmaceutical Preparations | 199 out of 1,391 | 86th |
Source: SEC filing on April 19, 2019.
Moriarty's colleagues
We found six more compensation records of executives who worked with John B. Moriarty, Jr. at Portola Pharmaceuticals in 2018.
2018
Scott Garland
Portola Pharmaceuticals
Chief Executive Officer
2018
William Lis
Portola Pharmaceuticals
Chief Executive Officer
2018
Glenn Brame
Portola Pharmaceuticals
Executive Vice President, Chief Technical Operations Officer
2018
Ernie Meyer
Portola Pharmaceuticals
Chief Human Resources Officer
2018
Mardi Dier
Portola Pharmaceuticals
Executive Vice President, Chief Financial and Business Officer
2018
John Curnutte
Portola Pharmaceuticals